A new generation of meglitinide oral hypoglycemic agents----Mitiglinide Calcium Tablets
Specification:5mg*15pieces*2
Oral Hypoglycemic DrugsPatients can take it orally.
Indications:
Improve postprandial hyperglycemia in patients with type 2 diabetes (only for diabetics, exercise therapy can not effectively control blood glucose in patients with diet, exercise therapy based on the addition of α-glucosidase inhibitors can not effectively control the blood sugar patient).
Dosage:
5 minutes before the meal orally. Usually adult 10mg (2 tablets), 3 times a day. According to the patient's treatment effect, as appropriate, adjust the dose.